RedHill Biopharma Ltd. (RDHL)
0.4825
0.00 (0.00%)
USD |
NASDAQ |
Oct 07, 16:00
0.4825
0.00 (0.00%)
After-Hours: 16:39
RedHill Biopharma Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | -11.41M |
| October 05, 2026 | -11.36M |
| October 02, 2026 | -11.32M |
| October 01, 2026 | -11.43M |
| September 30, 2026 | -11.43M |
| September 29, 2026 | -11.42M |
| September 28, 2026 | -11.30M |
| September 25, 2026 | -11.32M |
| September 24, 2026 | -11.22M |
| September 23, 2026 | -11.10M |
| September 22, 2026 | -11.11M |
| September 21, 2026 | -11.07M |
| September 18, 2026 | -10.98M |
| September 17, 2026 | -10.85M |
| September 16, 2026 | -11.07M |
| September 15, 2026 | -10.94M |
| September 14, 2026 | -10.74M |
| September 11, 2026 | -10.59M |
| September 10, 2026 | -10.54M |
| September 09, 2026 | -10.32M |
| September 08, 2026 | -10.56M |
| September 04, 2026 | -10.18M |
| September 03, 2026 | -10.24M |
| September 02, 2026 | -10.10M |
| September 01, 2026 | -9.440M |
| Date | Value |
|---|---|
| August 31, 2026 | -9.287M |
| August 28, 2026 | -10.50M |
| August 27, 2026 | -10.66M |
| August 26, 2026 | -10.74M |
| August 25, 2026 | -10.79M |
| August 24, 2026 | -10.79M |
| August 21, 2026 | -10.66M |
| August 20, 2026 | -10.69M |
| August 19, 2026 | -10.67M |
| August 18, 2026 | -10.85M |
| August 17, 2026 | -10.89M |
| August 14, 2026 | -10.81M |
| August 13, 2026 | -10.84M |
| August 12, 2026 | -10.87M |
| August 11, 2026 | -10.81M |
| August 10, 2026 | -10.91M |
| August 07, 2026 | -10.79M |
| August 06, 2026 | -10.91M |
| August 05, 2026 | -10.46M |
| August 04, 2026 | -10.57M |
| August 03, 2026 | -10.56M |
| July 31, 2026 | -10.56M |
| July 30, 2026 | -10.66M |
| July 29, 2026 | -10.39M |
| July 28, 2026 | -10.15M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 58.81B |
| MediWound Ltd. | 143.97M |
| Purple Biotech Ltd. | -3.650M |
| Sol-Gel Technologies Ltd. | 200.49M |
| PolyPid Ltd. | 99.00M |